Literature DB >> 27805426

The metabolomics and lipidomics window into thyroid cancer research.

R Farrokhi Yekta1, M Rezaie Tavirani1, A Arefi Oskouie2, M R Mohajeri-Tehrani3, A R Soroush4.   

Abstract

CONTEXT: Thyroid carcinoma is the most common endocrine system malignancy with a fast rising incidence in the last decade for unknown reasons. Fine needle aspiration (FNA) biopsy, the gold standard in thyroid cancer (TC) screening has still its own challenges and in some cases needs a proceeding surgery.
OBJECTIVE: This review highlights the role of the two most recent "omics" approaches, "metabolomics" and "lipidomics", in the field of TC research.
METHODS: All the previous studies have been extracted from the literature and major concepts were detailed in the field of TC metabolomics and lipidomics.
RESULTS: Metabolomics and lipidomics, have potential in finding biomarkers related to thyroid carcinoma. Among the previous studies, the most important introduced altered tissue metabolites and lipids included glucose and galactose, lactate, Scyllo- and Myo inositol, hypoxanthine, citrate, cholesterol and choline.
CONCLUSION: Metabolomics methods have been widely used in the field of biomarker discovery in TC and attempts are still in progress to use these methods to find a reliable biomarker panel besides current diagnostic tools.

Entities:  

Keywords:  Metabolomics; biomarker discovery; lipidomics; thyroid cancer

Mesh:

Substances:

Year:  2016        PMID: 27805426     DOI: 10.1080/1354750X.2016.1256429

Source DB:  PubMed          Journal:  Biomarkers        ISSN: 1354-750X            Impact factor:   2.658


  7 in total

1.  Mass Spectrometry-Based Shotgun Lipidomics for Cancer Research.

Authors:  Jianing Wang; Chunyan Wang; Xianlin Han
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  Lavandula angustifolia Effects on Rat Models of Alzheimer's Disease Through the Investigation of Serum Metabolic Features Using NMR Metabolomics.

Authors:  Afsaneh Arefi Oskouie; Reyhaneh Farrokhi Yekta; Mostafa Rezaei Tavirani; Masoud Soheili Kashani; Fatemeh Goshadrou
Journal:  Avicenna J Med Biotechnol       Date:  2018 Apr-Jun

Review 3.  Active surveillance as a management strategy for papillary thyroid microcarcinoma.

Authors:  Huan Zhang; Xiangqian Zheng; Juntian Liu; Ming Gao; Biyun Qian
Journal:  Cancer Biol Med       Date:  2020-08-15       Impact factor: 4.248

4.  Gut-Thyroid axis: How gut microbial dysbiosis associated with euthyroid thyroid cancer.

Authors:  Hafiz Muhammad Ishaq; Imran Shair Mohammad; Riaz Hussain; Rashida Parveen; Jafir Hussain Shirazi; Yang Fan; Muhammad Shahzad; Khezar Hayat; Huan Li; Ayesha Ihsan; Kiran Sher Muhammad; Muhammad Usman; Siruo Zhang; Lu Yuan; Shakir Ullah; Ana Cláudia Paiva-Santos; Jiru Xu
Journal:  J Cancer       Date:  2022-03-28       Impact factor: 4.207

Review 5.  Thyroid Cancer Diagnostics Related to Occupational and Environmental Risk Factors: An Integrated Risk Assessment Approach.

Authors:  Gabriela Maria Berinde; Andreea Iulia Socaciu; Mihai Adrian Socaciu; Andreea Cozma; Armand Gabriel Rajnoveanu; Gabriel Emil Petre; Doina Piciu
Journal:  Diagnostics (Basel)       Date:  2022-01-27

6.  Serum-based metabolic alterations in patients with papillary thyroid carcinoma unveiled by non-targeted 1H-NMR metabolomics approach.

Authors:  Reyhaneh Farrokhi Yekta; Mostafa Rezaei Tavirani; Afsaneh Arefi Oskouie; Mohammad Reza Mohajeri-Tehrani; Ahmad Reza Soroush; Alireza Akbarzadeh Baghban
Journal:  Iran J Basic Med Sci       Date:  2018-11       Impact factor: 2.699

Review 7.  Chronic kidney disease: a review of proteomic and metabolomic approaches to membranous glomerulonephritis, focal segmental glomerulosclerosis, and IgA nephropathy biomarkers.

Authors:  Amir Taherkhani; Reyhaneh Farrokhi Yekta; Maede Mohseni; Massoud Saidijam; Afsaneh Arefi Oskouie
Journal:  Proteome Sci       Date:  2019-12-20       Impact factor: 2.480

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.